Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab
SHANGHAI, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...
SHANGHAI, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven bio...
Read More
Other Stories in Health
- Women remain underserved in cardiovascular disease treatment despite advances
- Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab
- Through the eyes of a cat – biomimicry of feline eyes may revolutionize robotic vision
- 5 Lessons About Change I Learned from Moving to a New City
- Mpox clade 1b, the strain declared public health emergency by WHO, found in Kerala
- New York resident dies from EEE; state declares virus 'imminent public health threat'
- Pace University ABSN Spring 2025
- Health minister warns retailers still selling illegal vapes could soon face prosecution, months after ban took force
- Stage I vs. Stage IV: A Guide To Understanding Your Breast Cancer From Diagnosis To Treatment